v3.26.1
Description of Business, Organization, and Liquidity (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended
Sep. 16, 2024
Feb. 28, 2026
Dec. 31, 2025
Mar. 31, 2026
Subsidiary or Equity Method Investee [Line Items]        
Common stock, par value (in usd per share)     $ 0.0001 $ 0.0001
Proceeds from issuance on common stock and accompanying pre-funded warrants, net of issuance costs $ 332,400      
Cash, cash equivalents and investments       $ 539,800
Accumulated deficit     $ 358,966 $ 415,177
Pre-Funded Warrants        
Subsidiary or Equity Method Investee [Line Items]        
Common stock, par value (in usd per share)   $ 0.0001    
IPO        
Subsidiary or Equity Method Investee [Line Items]        
Number of shares issued in transaction (in shares) 20,125,000      
Common stock, par value (in usd per share) $ 0.0001      
Public offering price (in usd per share) $ 18.00      
ATM Program        
Subsidiary or Equity Method Investee [Line Items]        
Number of shares issued in transaction (in shares)     1,604,000  
Common stock, par value (in usd per share)     $ 0.0001  
Sale of stock, consideration received on transaction     $ 29,500  
February 2026 Offering        
Subsidiary or Equity Method Investee [Line Items]        
Sale of stock, consideration received on transaction   $ 161,800    
February 2026 Offering | Pre-Funded Warrants        
Subsidiary or Equity Method Investee [Line Items]        
Class of warrant or right, number of securities called by warrants or rights (in shares)   2,200,000    
Class of warrant or right, exercise price of warrants or rights (in usd per share)   $ 15.9999    
February 2026 Offering | Common Equity        
Subsidiary or Equity Method Investee [Line Items]        
Number of shares issued in transaction (in shares)   8,581,250    
Public offering price (in usd per share)   $ 16.00    
Over-Allotment Option        
Subsidiary or Equity Method Investee [Line Items]        
Number of shares issued in transaction (in shares)   1,406,250